Publisher： John Wiley & Sons Inc
E-ISSN： 1532-6535|96|2|214-223
ISSN： 0009-9236
Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.2, 2014-08, pp. : 214-223
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PD‐1 targeting in cancer immunotherapy
CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. :
Access to resources
Recommend
Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer
Oncology, Vol. 92, Iss. 5, 2017-02 ,pp. :
Interlaboratory concordance of
HISTOPATHOLOGY, Vol. 72, Iss. 3, 2018-02 ,pp. :
Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer
INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 7, 2015-10 ,pp. :